会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Use of phenoxy-pyridine derivatives
    • 使用苯氧基 - 吡啶衍生物
    • US5698565A
    • 1997-12-16
    • US639386
    • 1996-04-29
    • Thierry GodelDeborah HartmanClaus Riemer
    • Thierry GodelDeborah HartmanClaus Riemer
    • C07D211/70A61K31/44A61K31/4418
    • A61K31/4418
    • A method of treating or preventing illnesses caused by a disorder of the dopamine system. The method comprises administering to a host requiring such treatment or prevention an effective amount of a pharmaceutical composition comprising a compound of the formula ##STR1## wherein R.sup.1 is hydrogen, lower-alkyl, halogen, lower-alkoxy or nitro; R.sub.2 is hydrogen, lower alkyl or trifluoromethyl; and R.sup.3 is hydrogen, lower alkyl, trifluoromethyl, benzyl, hydroxy-lower-alkyl, lower alkoxy, lower-alkyl-carbonyl-amino, carbonyl-lower-alkyl, benzyl, di-lower-alkyl-amino-carbonyl, carbonylamino or amino-carbonyl-amino; or R.sup.2 and R.sup.3 together optionally are a fused benzene ring and R.sup.4 is hydrogen or halogen, or a pharmaceutically acceptable salt of a compound of formula I, and a pharmaceutically inert carrier material.
    • 治疗或预防由多巴胺系统紊乱引起的疾病的方法。 该方法包括向需要这种治疗或预​​防的宿主施用有效量的药物组合物,其包含下式化合物其中R 1是氢,低级烷基,卤素,低级烷氧基或硝基; R2是氢,低级烷基或三氟甲基; 低级烷基 - 氨基 - 羰基,羰基氨基或氨基,其中R 3为氢,低级烷基,三氟甲基,苄基,羟基 - 低级 - 烷基,低级烷氧基,低级 - - 羰基 - 氨基; 或R 2和R 3一起任选为稠合苯环,R 4为氢或卤素,或式I化合物的药学上可接受的盐和药学上惰性的载体材料。
    • 2. 发明授权
    • Use of phenoxy-piperzine derivatives
    • 苯氧基 - 哌嗪衍生物的使用
    • US5614526A
    • 1997-03-25
    • US639384
    • 1996-04-29
    • Thierry GodelDeborah HartmanClaus Riemer
    • Thierry GodelDeborah HartmanClaus Riemer
    • C07D295/08A61K31/34A61K31/341A61K31/495A61K31/496A61P25/00A61P25/18A61P43/00C07D307/68
    • A61K31/496A61K31/495
    • A method of treating or preventing illnesses caused by a disorder of the dopamine system. The method comprises administering to a host in need of such treatment or prevention an effective amount of a pharmaceutical composition comprising a compound of the formula ##STR1## wherein R.sup.1 and R.sup.3 each independently are hydrogen, aryl, carbamoyl, lower-alkyl-carbonyl, lower-alkyl, halogen, lower-alkyl-carbonyl-amino, lower-alkenyl-carbonyl-amino, amino, arylamino, aryloxy, nitro, aryl-acetyl, lower-alkanoyl-lower-alkyl, alkyl-sulphonyl-amino, ureido or furan-2-yl-carbonyl-amino andR.sup.2 is hydrogen, lower-alkyl, trifluoromethyl, halogen, lower-alkoxy, lower-alkyl-carbonyl or lower-alkyl-carbonyl-amino orR.sup.1 and R.sup.2 together are --OCH.sub.2 O--, --O(CH.sub.2).sub.2 O-- or --(CH.sub.2).sub.3 --,R.sup.4 is hydrogen, halogen, hydroxy, lower-alkyl, lower-alkoxy or nitro,R.sup.5 is hydrogen, halogen or lower-alkoxy,R.sup.6 is hydrogen, lower-alkyl, halogen, hydroxy, amino, lower-alkoxy, trifluoromethyl, nitro or lower-alkyl-carbonyl-amino andR.sup.7 is hydrogen or lower-alky-carbonyl,or a pharmaceutically acceptable salt of a compound of formula I, and a pharmaceutically inert carrier material.
    • 治疗或预防由多巴胺系统紊乱引起的疾病的方法。 该方法包括向需要这种治疗或预​​防的宿主施用有效量的包含下式化合物的药物组合物,其中R 1和R 3各自独立地为氢,芳基,氨基甲酰基,低级 - 烷基 - 羰基, 低级烷基,卤素,低级烷基 - 羰基 - 氨基,低级烯基 - 羰基 - 氨基,氨基,芳基氨基,芳氧基,硝基,芳基 - 乙酰基,低级 - 烷酰基 - 低级 - 烷基,烷基 - 磺酰基 - 氨基,脲基或 呋喃-2-基 - 羰基 - 氨基和R 2是氢,低级 - 烷基,三氟甲基,卤素,低级 - 烷氧基,低级 - 烷基 - 羰基或低级 - 烷基 - 羰基 - 氨基或R 1和R 2一起是-OCH 2 O-,-O( CH 2)2 O-或 - (CH 2)3 - ,R 4是氢,卤素,羟基,低级烷基,低级烷氧基或硝基,R 5是氢,卤素或低级烷氧基,R 6是氢,低级 - 烷基, ,氨基,低级烷氧基,三氟甲基,硝基或低级 - 烷基 - 羰基 - 氨基和R 7为氢或低级 - 羰基 - 或其药学上可接受的盐 mula I和药学惰性载体材料。